Anesthesia for spine surgery
If your insurance is not listed, please call our office if you have questions regarding your insurance coverage. If you have out-of-network benefits, then your insurance may reimburse you for a portion of your office visit. We will work with you and your insurance to minimize your out-of-pocket costs. Financial assistance may be available for patients in need.
Associate Attending Anesthesiologist, Hospital for Special Surgery
Clinical Associate Professor of Anesthesiology, Weill Cornell Medical College
Medical: Ludwig-Maximilians-University, Munich, Germany, 1995
Internship: University of Florida, Gainesville, 1999
Residency: University of Florida, Gainesville
Columbia University, New York, 2002
Fellowship: Critical Care at Columbia University, New York, 2003
English, Spanish, German, French, Polish
Book Chapter ICP Monitoring/ Acute ICP Increase The Anesthesia Guide, Atchabahian & Gupta, McGraw Hill
Poster Presentation at American Society of Anesthesiologists Annual Meeting "Craniotomy for Tumor: Head versus Heart? Brad Hamik M.D.; Mark Weller M.D. Columbia University/ New York Presbyterian Hospital, New York, NY
Abstract Presentation:"Irreversible Anaphylaxis in Living Donor Renal Transplant", Wiliam P Qiao MD, Mark Weller MD, International Anesthesia Research Society (IARS), Montreal, Canada
HSS has a long history of supporting appropriate relationships with industry because they advance HSS's mission to provide the highest quality patient care, improve patient mobility, and enhance the quality of life for all, and to advance the science of orthopedic surgery, rheumatology, and their related disciplines through research and education.
As of May 31, 2023, Dr. Weller reported no relationships with the healthcare industry.
HSS and its physicians make this information available to patients and the public, thus creating a transparent environment for those who are interested in this information. Further, the HSS Conflicts of Interest and Commitment Policy prohibits physicians from collecting royalties on products they develop that are used on patients at HSS.